Opportunity Information: Apply for PAR 13 318
Apply for PAR 13 318
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Revision Applications to P50 Awards for Research on Imaging and Biomarkers for Early Cancer Detection (P50)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.394 Cancer Detection and Diagnosis Research.
- This funding opportunity was created on Aug 7, 2013 and posted on Aug 6, 2013.
- Applicants must submit their applications by Dec 11, 2015. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $150,000.00 in funding.
- Eligible applicants include: State governments Special district governments City or township governments Native American tribal organizations (other than Federally recognized tribal governments) Independent school districts Private institutions of higher education Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses County governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) Public housing authorities/Indian housing authorities Small businesses Native American tribal governments (Federally recognized).
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity PAR 13 318, titled "Revision Applications to P50 Awards for Research on Imaging and Biomarkers for Early Cancer Detection (P50)," is a National Institutes of Health (NIH) funding announcement under the National Cancer Institute (NCI) that is specifically designed for existing NCI P50 Specialized Center awardees. It is not a stand-alone new center award. Instead, it supports revision applications (often called competing or non-competing revisions depending on context, but here framed as a revision mechanism) from currently funded SPOREs (Specialized Programs of Research Excellence) or ICMIC Specialized Centers that already operate under the NCI P50 grant mechanism. The overall purpose is to let these active center grants expand their research scope in a targeted way, by adding an additional project that strengthens the parent center's work in early cancer detection.
The scientific focus centers on improving cancer screening, early detection, and diagnostic approaches by bringing together two areas that are often developed separately: imaging technologies and biomarker science. NCI is looking for projects that intentionally combine imaging and biomarker strategies rather than treating them as parallel tracks. On the imaging side, the FOA emphasizes multi-modality imaging strategies, which generally means using more than one imaging method or platform in a coordinated way (for example, combining anatomical and functional imaging, or integrating imaging approaches that capture different biological features). On the biomarker side, the FOA highlights multiplexed biomarker methodologies, meaning approaches capable of measuring multiple biomarkers at once, potentially improving sensitivity, specificity, and overall clinical usefulness for detecting early-stage disease. The underlying idea is that integrating multi-modality imaging with multiplex biomarker measurements can produce stronger, more reliable early detection tools than either approach alone.
A key requirement is that the proposed work must correspond to an added project that expands the scope of the entire parent P50 award. In practical terms, the revision is expected to function as an extension of the center's overall research program rather than a small add-on or isolated experiment. The added project should fit within the center structure and contribute to the broader center objectives, leveraging the infrastructure, collaborations, and translational pathways typical of SPORE or ICMIC programs. The emphasis on early detection and diagnosis implies that applications should be oriented toward approaches that can realistically move the field toward earlier identification of cancers, improved characterization of suspicious findings, or better differentiation of benign versus malignant processes, with the combined imaging-biomarker framework as the centerpiece.
From an administrative standpoint, this is a discretionary grant opportunity with no cost-sharing or matching requirement. It falls under CFDA 93.394, Cancer Detection and Diagnosis Research, and is managed by NIH/NCI. The funding listing provides an award ceiling of $150,000, indicating the maximum amount available under this revision opportunity, which signals that the added project is intended to be focused and strategic rather than the scale of a full new center component. The opportunity was posted August 6, 2013, created August 7, 2013, had an original and final closing date of December 11, 2015, and was archived January 11, 2016, meaning it is no longer open but remains a useful reference for similar future NCI revision initiatives.
Eligibility is broad in terms of institutional types, but it is limited in practice to organizations that already hold eligible, active NCI P50 SPORE or ICMIC Specialized Center awards. The listing includes state and local governments, tribal organizations, public and private institutions of higher education, nonprofits (with and without 501(c)(3) status), for-profit organizations other than small businesses, small businesses, public housing authorities/Indian housing authorities, and other organizational categories described in the FOA. It also explicitly includes a range of mission-serving institutions such as HBCUs, Hispanic-serving institutions, tribally controlled colleges and universities, and Alaska Native and Native Hawaiian-serving institutions, among others. At the same time, it clearly restricts foreign participation: non-U.S. entities are not eligible to apply, non-U.S. components of U.S. organizations are not eligible, and foreign components as defined by the NIH Grants Policy Statement are not allowed.
For applicants needing the full details, NIH provided an official FOA link through the NIH Grants Guide (http://grants.nih.gov/grants/guide/pa-files/PAR-13-318.html). The contact information included is primarily for technical access or linking problems, directing users to the NIH Office of Extramural Research (OER) webmaster at FBOWebmaster@OD.NIH.GOV.
FAQs: PAR-13-318 (NCI/NIH) - Revision Applications to P50 Awards for Research on Imaging and Biomarkers for Early Cancer Detection (P50)
What is PAR-13-318?
PAR-13-318 is a National Institutes of Health (NIH) funding announcement from the National Cancer Institute (NCI) titled "Revision Applications to P50 Awards for Research on Imaging and Biomarkers for Early Cancer Detection (P50)." It supports revision applications to certain existing NCI P50 Specialized Center awards.
Is this a stand-alone grant for creating a new center?
No. This opportunity is not a new, stand-alone center award. It is specifically designed to fund revision applications to already-funded NCI P50 center grants.
Who is this opportunity intended for?
It is intended for organizations that already hold eligible, active NCI P50 Specialized Center awards, specifically currently funded SPOREs (Specialized Programs of Research Excellence) or ICMIC Specialized Centers operating under the NCI P50 mechanism.
What is the purpose of this revision opportunity?
The purpose is to allow active NCI P50 centers to expand their research scope in a targeted way by adding an additional project that strengthens the parent center's work in early cancer detection.
What kind of work is NCI looking to support scientifically?
The scientific focus is on improving cancer screening, early detection, and diagnostic approaches by intentionally integrating imaging technologies and biomarker science, rather than developing them as separate parallel tracks.
What does "integrating imaging and biomarkers" mean in this FOA?
In this FOA, integration means the proposed added project should combine imaging strategies and biomarker strategies into a unified approach for early cancer detection and diagnosis, with the combined imaging-biomarker framework as the centerpiece.
What does the FOA mean by "multi-modality imaging strategies"?
Multi-modality imaging generally means using more than one imaging method or platform in a coordinated way, such as combining different types of imaging that capture different biological or anatomical features.
What does the FOA mean by "multiplexed biomarker methodologies"?
Multiplexed biomarker methodologies refer to approaches capable of measuring multiple biomarkers at once, with the goal of improving sensitivity, specificity, or clinical usefulness for detecting early-stage disease.
Does the revision need to be a full new program, or can it be a small add-on?
The revision is expected to add a project that expands the scope of the entire parent P50 award. It should function as an extension of the center's overall research program, fitting within the center structure and contributing to broader center objectives, rather than being an isolated experiment.
What types of parent P50 centers are specifically mentioned as eligible?
The opportunity is framed for currently funded SPOREs (Specialized Programs of Research Excellence) or ICMIC Specialized Centers that already operate under the NCI P50 grant mechanism.
What is the maximum funding amount listed for this revision opportunity?
The funding listing provides an award ceiling of $150,000, indicating the maximum amount available under this revision opportunity.
Is there any cost-sharing or matching requirement?
No. The opportunity is described as discretionary and states there is no cost-sharing or matching requirement.
Which federal agency and institute manage this opportunity?
This opportunity is managed by NIH, specifically the National Cancer Institute (NCI).
What is the CFDA number associated with this grant opportunity?
The opportunity is listed under CFDA 93.394, Cancer Detection and Diagnosis Research.
When was this opportunity posted, and is it still open?
It was posted on August 6, 2013, and created on August 7, 2013. The original and final closing date was December 11, 2015, and it was archived on January 11, 2016. It is no longer open.
What kinds of organizations are listed as eligible in the announcement?
The listing includes a wide range of organizational types, including state and local governments, tribal organizations, public and private institutions of higher education, nonprofits (with and without 501(c)(3) status), for-profit organizations other than small businesses, small businesses, public housing authorities/Indian housing authorities, and other organizational categories described in the FOA.
Are certain mission-serving institutions explicitly included?
Yes. The opportunity explicitly includes categories such as HBCUs, Hispanic-serving institutions, tribally controlled colleges and universities, and Alaska Native and Native Hawaiian-serving institutions, among others.
If eligibility is broad, why does it still say participation is limited in practice?
Because even though many organization types are listed, applicants must already hold an eligible, active NCI P50 SPORE or ICMIC Specialized Center award to submit a revision application under this opportunity.
Are non-U.S. (foreign) organizations eligible to apply?
No. Non-U.S. entities are not eligible to apply.
Can a U.S. organization include a non-U.S. component on its application?
No. Non-U.S. components of U.S. organizations are not eligible, and foreign components (as defined by the NIH Grants Policy Statement) are not allowed.
Where can applicants find the official FOA details?
The official FOA is provided through the NIH Grants Guide at: http://grants.nih.gov/grants/guide/pa-files/PAR-13-318.html
Who should be contacted for technical access or linking problems related to the FOA?
The contact provided for technical access or linking problems is the NIH Office of Extramural Research (OER) webmaster at FBOWebmaster@OD.NIH.GOV.
Browse more opportunities from the same category: Education Health
Next opportunity: Western Invasives Network (WIN)
Previous opportunity: Revision Applications to P01 Awards for Research on Imaging and Biomarkers for Early Cancer Detection (P01)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 13 318
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 13 318) also looked into and applied for these:
| Funding Opportunity |
|---|
| National Cancer Institute Program Project Applications (P01) Apply for PAR 13 321 Funding Number: PAR 13 321 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Increased Knowledge and Innovative Strategies to Reduce HIV IncidenceiKnow Projects (R01) Apply for PAR 13 323 Funding Number: PAR 13 323 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Innovative Molecular Analysis Technology Development for Cancer Research and Clinical Care (SBIR R43/44) Apply for PAR 13 327 Funding Number: PAR 13 327 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Revisions for Early Stage Development of Informatics Technology (P01) Apply for PAR 13 330 Funding Number: PAR 13 330 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| Health Promotion Among Racial and Ethnic Minority Males (R21) Apply for PA 13 331 Funding Number: PA 13 331 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Strategic Alliances for Medications Development to Treat Substance Use Disorders (R01) Apply for PAR 13 334 Funding Number: PAR 13 334 Agency: National Institutes of Health Category: Education Health Funding Amount: $3,000,000 |
| Neuroscience Research on Drug Abuse (R21) Apply for PA 13 337 Funding Number: PA 13 337 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Neuroscience Research on Drug Abuse (R03) Apply for PA 13 336 Funding Number: PA 13 336 Agency: National Institutes of Health Category: Education Health Funding Amount: $100,000 |
| Neuroscience Research on Drug Abuse (R01) Apply for PA 13 338 Funding Number: PA 13 338 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Mechanisms of Alcohol and Stimulant Co Addiction (R01) Apply for PA 13 339 Funding Number: PA 13 339 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Mechanisms of Alcohol and Stimulant Co Addiction (R21) Apply for PA 13 340 Funding Number: PA 13 340 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Early Career Award in Chemistry of Drug Abuse and Addiction (ECHEM) (R21/R33) Apply for PAR 13 350 Funding Number: PAR 13 350 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| National Institute on Drug Abuse National Early Warning System (NEWS) Coordinating Center (U01) Apply for RFA DA 14 015 Funding Number: RFA DA 14 015 Agency: National Institutes of Health Category: Education Health Funding Amount: $900,000 |
| Research Answers to NCIs Provocative Questions Group A (R01) Apply for RFA CA 13 016 Funding Number: RFA CA 13 016 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Research Answers to NCIs Provocative Questions Group A (R21) Apply for RFA CA 13 017 Funding Number: RFA CA 13 017 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Research Answers to NCIs Provocative Questions Group B (R01) Apply for RFA CA 13 018 Funding Number: RFA CA 13 018 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Research Answers to NCIs Provocative Questions Group C (R01) Apply for RFA CA 13 020 Funding Number: RFA CA 13 020 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Research Answers to NCIs Provocative Questions Group D (R01) Apply for RFA CA 13 022 Funding Number: RFA CA 13 022 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Research Answers to NCIs Provocative Questions Group D (R21) Apply for RFA CA 13 023 Funding Number: RFA CA 13 023 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Research Answers to NCIs Provocative Questions Group B (R21) Apply for RFA CA 13 019 Funding Number: RFA CA 13 019 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 13 318", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
